Author

P. N. Ostermann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:protein sequence· 1

Frequent Co-Authors

H. Schaal· 3 shared L. Mueller· 3 shared O. Adams· 3 shared A. Borkhardt· 1 shared A. F. Lingappa· 1 shared A. Macieik· 1 shared A. Mueller-Schiffmann· 1 shared A. R. Moreira· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

H. Schaal

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MMR vaccination induces a trained immunity program characterized by functional and metabolic reprogramming of γδ T cells

R. J. Roring, P. A. Debisarun, J. Botey-Bataller, K. T. Suen, O. Bulut, G. Kilic, V. A. C. M. Koeken, A. Sarlea, H. Bahrar, H. Dijkstra, H. Lemmers, K. L. Goessling, N. Ruechel, P. N. Ostermann, L. Mueller, , M. G. Netea

MMR vaccination induces functional and metabolic reprogramming of γδ T cells, enhancing their activation and cytokine production.

bioRxiv · Nov 24, 2022 · PreprintImmunology

Design of D-amino acids SARS-CoV-2 Main protease inhibitors using the cationic peptide from rattlesnake venom as a scaffold

R. J. Eberle, I. Gering, M. Tusche, P. N. Ostermann, L. Mueller, O. Adams, H. Schaal, D. S. Olivier, M. S. Amaral, R. K. Arni, D. Willbold, M. Coronado

The paper designs D-amino acid-based inhibitors of SARS-CoV-2 3CLpro using a rattlesnake venom peptide scaffold, showing in vitro and in vivo antiviral activity.

bioRxiv · Nov 10, 2021Biochemistry

A Pan-respiratory Antiviral Chemotype Targeting a Host Multiprotein Complex

M. Michon, A. Mueller-Schiffmann, A. F. Lingappa, S. F. Yu, L. Du, F. Deiter, S. Mallesh, J. Crabtree, U. F. Lingappa, A. Macieik, L. Mueller, P. N. Ostermann, M. Andree, O. Adams, H. Schaal, , K

The paper identifies a novel antiviral chemotype effective against multiple respiratory viruses by targeting a host multi-protein complex involved in viral lifecycle and innate immunity.

bioRxiv · Jan 17, 2021Biochemistry